Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML - HSA Drug Approval Details

Approvals/HSA/XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

Approved

THERAPEUTIC

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

Aspiro Pharma Limited (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Jun 12, 2020
Approval ID: c7666fb43e622a86
Company: Aspiro Pharma Limited (INDIA)
Type: Therapeutic

Approval Details

Approval Id: c7666fb43e622a86
Drug Name: XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML
Product Name: XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML
Approval Number: SIN15952P
Approval Date: 2020-06-12
Registrant: HETERO SINGAPORE PTE. LTD.
Licence Holder: HETERO SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: N01BB02
Atc Item Name: lidocaine
Pharma Manufacturer Name: HETERO SINGAPORE PTE. LTD.

Active Ingredients

Lidocaine Hydrochloride

50mg/5ml

LIDOCAINE HYDROCHLORIDE

50 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 12, 2020

Approval ID

c7666fb43e622a86

Type

Therapeutic

Back to HSA Approvals